Clinical Trials Sponsored by ARS Pharmaceuticals, Inc.

Total 5096 results

ARS Pharmaceuticals, Inc.

Active, not recruiting

Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma

Asthma

United States
ARS Pharmaceuticals, Inc.

Active, not recruiting

Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares

Urticaria

United States
ARS Pharmaceuticals, Inc.

Completed

Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection

Upper Respiratory Tract Infection

Australia
ZARS Pharma Inc.
Endo Pharmaceuticals

Completed

Evaluate the Depth and Duration of Anesthesia

Pain

United States
Hinova Pharmaceuticals Aus Pty Ltd

Completed

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Australia
Ionis Pharmaceuticals, Inc.
ALS Association; Muscular Dystrophy Association

Completed

Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations (SOD-1)

Familial Amyotrophic Lateral Sclerosis

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Chronic HBV Infection

United States, Canada
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
Ark Biosciences Inc.

Completed

A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

Healthy

China
ARJ Medical, Inc.

Completed

ARJ C13 Urea Breath Test System

H. Pylori Infection

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Pain

United States
ZARS Pharma Inc.

Completed

Duration of Skin Numbing Effect Created by the S-Caine™ Peel

Pain

United States
ZARS Pharma Inc.

Completed

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

Pain | Osteoarthritis, Knee

United States
ZARS Pharma Inc.

Completed

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

Myofascial Pain Syndromes

United States
ZARS Pharma Inc.

Terminated

A Phase 3 Study to Evaluate the Long-Term Safety of ThermoProfen™ in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee.

Osteoarthritis

United States
ZARS Pharma Inc.

Completed

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults

Pain

United States
Ark Biosciences Inc.

Unknown

Anti-RSV Study in Chinese Patients (ASCENT) (ASCENT)

Respiratory Syncytial Virus Infections

China
Ark Biosciences Inc.

Completed

A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529

Healthy

United Kingdom
ZARS Pharma Inc.

Completed

Pharmacokinetic Study of Synera in Healthy Volunteers

Healthy

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Pain

United States
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults

Pain

United States
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face

Pain

United States
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

Pain

United States
ZARS Pharma Inc.

Terminated

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Pain | Cancer

United States
ZARS Pharma Inc.

Completed

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain

Pain

United States
ZARS Pharma Inc.

Completed

Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis (TAC-202)

Hand Dermatoses

United States
AIDS Arms Inc.

Completed

A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort

HIV-1 | AIDS

United States
ARJ Medical, Inc.

Recruiting

PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study

Helicobacter Pylori Infection | Efficacy | Post-Treatment

United States
ARJ Medical, Inc.

Recruiting

PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study

Efficacy | Safety | Helicobacter Pylori

United States
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Ark Biosciences Inc.

Completed

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Healthy

Sweden
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
Ark Biosciences Inc.

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Respiratory Syncytial Virus Infections

Australia
ZARS Pharma Inc.

Completed

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults

Pain

United States
ZARS Pharma Inc.

Completed

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children

Pain

United States
ZARS Pharma Inc.

Completed

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

Osteoarthritis

United States
ZARS Pharma Inc.

Completed

Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)

Postherpetic Neuralgia

United States
ZARS Pharma Inc.

Suspended

Pharmacokinetic Study of Synera™ in Neonates and Infants

Pain

United States
ZARS Pharma Inc.

Completed

Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome

Shoulder Impingement Syndrome

United States
ZARS Pharma Inc.

Completed

Study Evaluating a Heated Lidocaine and Tetracaine Topical Patch in the Treatment of Patients With Patellar Tendinopathy

Patellar Tendinopathy

United States
ZARS Pharma Inc.

Completed

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Children

Pain

United States
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

Pain | Advanced Cancer

United States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS (OS440-3004)

Multiple Sclerosis | Spasticity, Muscle

Serbia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Moldova, Republic of, Poland

3

Subscribe